Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy.

Hrycushko B, van der Kogel AJ, Phillips L, Folkert MR, Sayre JW, Vernino S, Hassan-Rezaeian N, Foster RD, Yamada Y, Timmerman R, Medin PM.

Int J Radiat Oncol Biol Phys. 2019 Apr 4. pii: S0360-3016(19)30571-1. doi: 10.1016/j.ijrobp.2019.03.044. [Epub ahead of print]

PMID:
30953713
2.

Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Braunstein S, Wang L, Newhauser W, Tenenholz T, Rong Y, van der Kogel A, Dominello M, Joiner MC, Burmeister J.

J Appl Clin Med Phys. 2019 Feb;20(2):7-12. doi: 10.1002/acm2.12537. Epub 2019 Feb 8. No abstract available.

3.

Corrigendum: Potential role of the glycolytic oscillator in acute hypoxia in tumors (2015 <i>Phys. Med. Biol.</i> 60 9215).

Che Fru L, Adamson EB, Campos DD, Fain SB, Jacques SL, van der Kogel AJ, Nickel KP, Song C, Kimple RJ, Kissick MW.

Phys Med Biol. 2018 Jun 6. doi: 10.1088/1361-6560/aacaba. [Epub ahead of print]

PMID:
29873307
4.

Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016).

Harari PM, Ritter MA, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):886-888. doi: 10.1016/j.ijrobp.2017.01.015. Epub 2017 Jan 10. No abstract available.

PMID:
28333004
5.

Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.

Campos D, Peeters W, Nickel K, Burkel B, Bussink J, Kimple RJ, van der Kogel A, Eliceiri KW, Kissick MW.

Radiat Res. 2016 May;185(5):496-504. doi: 10.1667/RR14093.1. Epub 2016 Apr 29.

6.

Potential role of the glycolytic oscillator in acute hypoxia in tumors.

Fru LC, Adamson EB, Campos DD, Fain SB, Jacques SL, van der Kogel AJ, Nickel KP, Song C, Kimple RJ, Kissick MW.

Phys Med Biol. 2015 Dec 21;60(24):9215-25. doi: 10.1088/0031-9155/60/24/9215. Epub 2015 Nov 18.

7.

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers.

Li C, Huang S, Armstrong EA, Francis DM, Werner LR, Sliwkowski MX, van der Kogel A, Harari PM.

Mol Cancer Ther. 2015 Sep;14(9):2049-59. doi: 10.1158/1535-7163.MCT-15-0155. Epub 2015 Jul 3.

8.

Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.

Stegeman H, Rademakers SE, Span PN, Takes RP, van der Kogel AJ, Kaanders JH, Bussink J.

Head Neck. 2014 Sep;36(9):1288-95. doi: 10.1002/hed.23446. Epub 2013 Nov 6.

PMID:
24668936
9.

Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Hoeben BA, Starmans MH, Leijenaar RT, Dubois LJ, van der Kogel AJ, Kaanders JH, Boutros PC, Lambin P, Bussink J.

BMC Cancer. 2014 Feb 26;14:130. doi: 10.1186/1471-2407-14-130.

10.

Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.

Rademakers SE, Hoogsteen IJ, Rijken PF, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, van der Kogel AJ, Bussink J, Kaanders JH.

Head Neck. 2015 Feb;37(2):171-6. doi: 10.1002/hed.23569. Epub 2014 Feb 12.

PMID:
24347430
11.

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.

Stegeman H, Kaanders JH, Verheijen MM, Peeters WJ, Wheeler DL, Iida M, Grénman R, van der Kogel AJ, Span PN, Bussink J.

Mol Cancer. 2013 Nov 5;12(1):133. doi: 10.1186/1476-4598-12-133.

12.

Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology.

Baumann M, Bodis S, Dikomey E, van der Kogel A, Overgaard J, Rodemann HP, Wouters B.

Radiother Oncol. 2013 Sep;108(3):357-61. doi: 10.1016/j.radonc.2013.10.001. No abstract available.

PMID:
24183263
13.

On the importance of prompt oxygen changes for hypofractionated radiation treatments.

Kissick M, Campos D, van der Kogel A, Kimple R.

Phys Med Biol. 2013 Oct 21;58(20):N279-85. doi: 10.1088/0031-9155/58/20/N279. Epub 2013 Sep 24.

14.

Paralysis following stereotactic spinal irradiation in pigs suggests a tolerance constraint for single-session irradiation of the spinal nerve.

Medin PM, Foster RD, van der Kogel AJ, Meyer J, Sayre JW, Huang H, Öz OK.

Radiother Oncol. 2013 Oct;109(1):107-11. doi: 10.1016/j.radonc.2013.08.025. Epub 2013 Sep 20.

15.

EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair.

Stegeman H, Span PN, Cockx SC, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH, Bussink J.

Radiat Res. 2013 Oct;180(4):414-21. doi: 10.1667/RR3349.2. Epub 2013 Sep 23.

PMID:
24059677
16.
17.

Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.

Stegeman H, Span PN, Rijken PF, Cockx SC, Wheeler DL, Iida M, van der Kogel AJ, Kaanders JH, Bussink J.

Transl Oncol. 2013 Aug 1;6(4):413-9. Print 2013 Aug.

18.

The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response.

Nagelkerke A, Bussink J, van der Kogel AJ, Sweep FC, Span PN.

Radiother Oncol. 2013 Sep;108(3):415-21. doi: 10.1016/j.radonc.2013.06.037. Epub 2013 Jul 25.

PMID:
23891100
19.

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.

Nijkamp MM, Span PN, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende PL, de Jong M, van der Kogel AJ, Bussink J, Kaanders JH.

Eur J Cancer. 2013 Oct;49(15):3202-9. doi: 10.1016/j.ejca.2013.06.024. Epub 2013 Jul 15.

20.

Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation.

Baker LC, Boult JK, Jamin Y, Gilmour LD, Walker-Samuel S, Burrell JS, Ashcroft M, Howe FA, Griffiths JR, Raleigh JA, van der Kogel AJ, Robinson SP.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):160-7. doi: 10.1016/j.ijrobp.2013.04.051. Epub 2013 Jul 9.

PMID:
23849692
21.

Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.

Rademakers SE, Hoogsteen IJ, Rijken PF, Oosterwijk E, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, Takes R, De Bree R, van der Kogel AJ, Bussink J, Kaanders JH.

Radiother Oncol. 2013 Sep;108(3):517-22. doi: 10.1016/j.radonc.2013.04.022. Epub 2013 May 26.

PMID:
23719582
22.

PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS.

Rouschop KM, Dubois LJ, Keulers TG, van den Beucken T, Lambin P, Bussink J, van der Kogel AJ, Koritzinsky M, Wouters BG.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4622-7. doi: 10.1073/pnas.1210633110. Epub 2013 Mar 7.

23.

Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.

Stegeman H, Kaanders JH, van der Kogel AJ, Iida M, Wheeler DL, Span PN, Bussink J.

Radiother Oncol. 2013 Mar;106(3):383-9. doi: 10.1016/j.radonc.2013.02.001. Epub 2013 Feb 28.

24.

Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units.

Bentzen SM, Dörr W, Gahbauer R, Howell RW, Joiner MC, Jones B, Jones DT, van der Kogel AJ, Wambersie A, Whitmore G.

Radiother Oncol. 2012 Nov;105(2):266-8. doi: 10.1016/j.radonc.2012.10.006. Epub 2012 Nov 15.

PMID:
23157980
25.

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.

Stegeman H, Kaanders JH, Wheeler DL, van der Kogel AJ, Verheijen MM, Waaijer SJ, Iida M, Grénman R, Span PN, Bussink J.

BMC Cancer. 2012 Oct 10;12:463. doi: 10.1186/1471-2407-12-463.

26.

Spinal cord tolerance to single-session uniform irradiation in pigs: implications for a dose-volume effect.

Medin PM, Foster RD, van der Kogel AJ, Sayre JW, McBride WH, Solberg TD.

Radiother Oncol. 2013 Jan;106(1):101-5. doi: 10.1016/j.radonc.2012.08.007. Epub 2012 Sep 14.

27.

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.

Hansen AE, Kristensen AT, Jørgensen JT, McEvoy FJ, Busk M, van der Kogel AJ, Bussink J, Engelholm SA, Kjær A.

Radiat Oncol. 2012 Jun 15;7:89. doi: 10.1186/1748-717X-7-89.

28.

SU-E-T-06: A Mathematical Explanation to Tumor's Response to Perfusion and Hypoxic Fraction after Radiation.

Yan Y, Kissick M, Bussink J, Jacques S, van der Kogel A, Campos D, Zhao D.

Med Phys. 2012 Jun;39(6Part9):3703. doi: 10.1118/1.4735060.

PMID:
28519053
29.

SU-E-J-196: In-Vivo Tumor Blood-Oxygen Content Measurement via Interstitial Optical Transmission Spectroscopy.

Campos D, Yan Y, Zhao D, Kissick M, Jacques S, van der Kogel A, Kimple R.

Med Phys. 2012 Jun;39(6Part9):3698. doi: 10.1118/1.4735037.

PMID:
28519036
30.

SU-E-J-197: A Novel Optical Interstitial Fiber Spectroscopic System for Real-Time Tissue Micro-Vascular Hemodynamics Monitoring.

Zhao D, Campos D, Yan Y, Kimple R, Jacques S, van der Kogel A, Kissick M.

Med Phys. 2012 Jun;39(6Part9):3698. doi: 10.1118/1.4735038.

PMID:
28519022
31.

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR.

Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75.

32.

Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.

Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Marres HA, de Bree R, van der Kogel AJ, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH.

J Clin Oncol. 2012 May 20;30(15):1777-83. doi: 10.1200/JCO.2011.35.9315. Epub 2012 Apr 16.

PMID:
22508814
33.

Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model.

Medin PM, Foster RD, van der Kogel AJ, Sayre JW, McBride WH, Solberg TD.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1031-7. doi: 10.1016/j.ijrobp.2011.08.030. Epub 2011 Dec 22.

34.

Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.

Dubois LJ, Lieuwes NG, Janssen MH, Peeters WJ, Windhorst AD, Walsh JC, Kolb HC, Ollers MC, Bussink J, van Dongen GA, van der Kogel A, Lambin P.

Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14620-5. doi: 10.1073/pnas.1102526108. Epub 2011 Aug 23.

35.

Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

Bowen SR, van der Kogel AJ, Nordsmark M, Bentzen SM, Jeraj R.

Nucl Med Biol. 2011 Aug;38(6):771-80. doi: 10.1016/j.nucmedbio.2011.02.002. Epub 2011 May 5.

36.

Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.

Nijkamp MM, Hoogsteen IJ, Span PN, Takes RP, Lok J, Rijken PF, van der Kogel AJ, Bussink J, Kaanders JH.

Radiother Oncol. 2011 Oct;101(1):165-70. doi: 10.1016/j.radonc.2011.06.022. Epub 2011 Jul 19.

PMID:
21775008
37.

Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients.

Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J.

Radiother Oncol. 2011 Jun;99(3):344-8. doi: 10.1016/j.radonc.2011.05.066. Epub 2011 Jun 22.

PMID:
21684617
38.

Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.

Rouschop KM, Dubois L, Schaaf MB, van den Beucken T, Lieuwes N, Keulers TG, Savelkouls KG, Bussink J, van der Kogel AJ, Koritzinsky M, Wouters BG.

Radiother Oncol. 2011 Jun;99(3):385-91. doi: 10.1016/j.radonc.2011.05.047. Epub 2011 Jun 12.

PMID:
21665307
39.

Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.

Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH.

BMC Cancer. 2011 May 12;11:167. doi: 10.1186/1471-2407-11-167.

40.

Spinal cord tolerance to single-fraction partial-volume irradiation: a swine model.

Medin PM, Foster RD, van der Kogel AJ, Sayre JW, McBride WH, Solberg TD.

Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):226-32. doi: 10.1016/j.ijrobp.2010.07.1979. Epub 2010 Oct 8.

41.
42.

Benign uterine uptake of FDG: a case report and review of literature.

Vriens D, de Geus-Oei LF, Flucke UE, van der Kogel AJ, Oyen WJ, Vierhout ME, van der Meer JW.

Neth J Med. 2010 Sep;68(9):379-80. Review. No abstract available.

43.

Effect of cetuximab and fractionated irradiation on tumour micro-environment.

Santiago A, Eicheler W, Bussink J, Rijken P, Yaromina A, Beuthien-Baumann B, van der Kogel AJ, Baumann M, Krause M.

Radiother Oncol. 2010 Nov;97(2):322-9. doi: 10.1016/j.radonc.2010.07.007.

PMID:
20667608
44.

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Kruser TJ, Wheeler DL, Armstrong EA, Iida M, Kozak KR, van der Kogel AJ, Bussink J, Coxon A, Polverino A, Harari PM.

Clin Cancer Res. 2010 Jul 15;16(14):3639-47. doi: 10.1158/1078-0432.CCR-09-3385. Epub 2010 May 27.

45.

Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.

Gambarota G, van Laarhoven HW, Philippens M, Peeters WJ, Rijken P, van der Kogel A, Punt CJ, Heerschap A.

Appl Magn Reson. 2010 Jun;38(3):349-360. Epub 2010 Mar 28.

46.

Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.

Troost EG, Bussink J, Slootweg PJ, Peeters WJ, Merkx MA, van der Kogel AJ, Oyen WJ, Kaanders JH.

J Nucl Med. 2010 May;51(5):713-9. doi: 10.2967/jnumed.109.071910. Epub 2010 Apr 15.

47.

Radiation dose-volume effects in the spinal cord.

Kirkpatrick JP, van der Kogel AJ, Schultheiss TE.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S42-9. doi: 10.1016/j.ijrobp.2009.04.095. Review.

PMID:
20171517
48.

The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5.

Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG.

J Clin Invest. 2010 Jan;120(1):127-41. doi: 10.1172/JCI40027. Epub 2009 Dec 14.

49.

Innovations in radiotherapy planning of head and neck cancers: role of PET.

Troost EG, Schinagl DA, Bussink J, Boerman OC, van der Kogel AJ, Oyen WJ, Kaanders JH.

J Nucl Med. 2010 Jan;51(1):66-76. doi: 10.2967/jnumed.108.061499. Epub 2009 Dec 15. Review.

50.

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der Kogel A, Overgaard J.

Radiother Oncol. 2009 Sep;92(3):429-36. doi: 10.1016/j.radonc.2009.08.026. Epub 2009 Sep 2.

PMID:
19729214

Supplemental Content

Loading ...
Support Center